'Test to Treat' gets COVID pills to at-risk patients fast but its reach is limited
The Biden administration's new program enables high-risk patients who test positive to get antiviral pills on the spot in some pharmacies. But many pharmacies won't be able to participate.
by Pien Huang
Mar 08, 2022
4 minutes
Starting this week, high-risk patients with COVID symptoms will be able to walk into hundreds of pharmacy-based clinics for a free test – and walk out with a free course of COVID treatment pills.
It's the start of a new initiative from the Biden administration, and it's a key feature of the President's national COVID preparedness plan. "I've ordered more pills than anyone in the world has," Biden said in his State of the Union address March 1, "And now, we're launching the 'Test to Treat' initiative so people can get tested at a pharmacy and, if they prove positive, receive the antiviral pills on the spot at no cost."
The program aims to speed up
You’re reading a preview, subscribe to read more.
Start your free 30 days